SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-21-234994
Filing Date
2021-08-03
Accepted
2021-08-03 16:31:33
Documents
8

Document Format Files

Seq Description Document Type Size
1 SC14D9C d365379dsc14d9c.htm SC14D9C 9040
2 EX-99.1 d365379dex991.htm EX-99.1 17108
3 EX-99.2 d365379dex992.htm EX-99.2 76270
4 EX-99.3 d365379dex993.htm EX-99.3 13164
5 EX-99.4 d365379dex994.htm EX-99.4 12767
6 GRAPHIC g365379g0803222523509.jpg GRAPHIC 48963
7 GRAPHIC g365379g0803222523743.jpg GRAPHIC 33494
8 GRAPHIC g365379g0803222523930.jpg GRAPHIC 48256
  Complete submission text file 0001193125-21-234994.txt   310575
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filed by) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Subject) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-90547 | Film No.: 211140345
SIC: 2836 Biological Products, (No Diagnostic Substances)